Méndez-Sánchez N

Language: English
References: 6
Page: 433-434
PDF size: 57.95 Kb.

Text Extraction

I was recently informed by the American Association for the Study of Liver Diseases about the loss of Paul Angulo. It was very surprising for me that such a young, enthusiastic and productive hepatologist has passed away and I want to take the opportunity to write about my friend and colleague Paul Angulo.

REFERENCES

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.

2. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45: 846-54.

3. Angulo P, Bugianesi E, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Barrera F, Haflidadottir S, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013; 145: 782-9.

4. Angulo P, Therneau TM, Jorgensen A, DeSotel CK, Egan KS, Dickson ER, Hay JE, et al. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998; 29: 729-35.

5. Angulo P, Grandison GA, Fong DG, Keach JC, Lindor KD, Bjornsson E, Koch A. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 2011; 140: 180-8.

6. Angulo P. Treatment of nonalcoholic fatty liver disease. Ann Hepatol 2002; 1: 12-9.